RESUMO
INTRODUCTION: Direct comparison of the effects of antiarrhythmic agents on myocardial performance may be useful in choosing between medications in critically ill patients. Studies directly comparing multiple antiarrhythmic medications are lacking. The use of an experimental heart preparation permits examination of myocardial performance under constant loading conditions. METHODS: Hearts of Sprague Dawley rats (n = 35, 402-507 g) were explanted and cannulated in working heart model with fixed preload and afterload. Each heart was then exposed to a 3-hour infusion of procainamide (20 µg/kg/min), esmolol (100 or 200 µg/kg/min), amiodarone (10 or 20 mg/kg/d), sotalol (80 mg/m2/d), or placebo infusions (n = 5 per dose). Cardiac output, contractility (dP/dTmax), diastolic performance (dP/dTmin), and heart rate were compared between groups over time by linear mixed modeling. RESULTS: Compared with placebo, sotalol decreased contractility by an average of 24% ( P < .001) over the infusion period, as did amiodarone (low dose by 13%, P = .029; high dose by 14%, P = .013). Compared with placebo, mean cardiac output was significantly lower in animals treated with sotalol (by 22%, P = .016) and esmolol 200 µg/kg/min (by 23%, P = .012). Over time, amiodarone decreased cardiac output (20 mg/kg/d, ß = -89 [-144, -33] µL/min2 decrease, P = .002) and also worsened diastolic function, decreasing dP/dTmin by â¼18% and 22% ( P = .032 and P = .011, low and high doses, respectively). Procainamide did not have a significant effect on any measures of systolic or diastolic performance. CONCLUSIONS: In isolated hearts, amiodarone and sotalol depressed myocardial contractility, cardiac output, and diastolic function. However, procainamide did not negatively affect myocardial performance and represents a favorable agent in settings of therapeutic equivalence.
Assuntos
Amiodarona/administração & dosagem , Antiarrítmicos/administração & dosagem , Débito Cardíaco/efeitos dos fármacos , Contração Miocárdica/efeitos dos fármacos , Procainamida/administração & dosagem , Sotalol/administração & dosagem , Função Ventricular Esquerda/efeitos dos fármacos , Amiodarona/toxicidade , Animais , Antiarrítmicos/toxicidade , Relação Dose-Resposta a Droga , Infusões Intravenosas , Preparação de Coração Isolado , Procainamida/toxicidade , Ratos Sprague-Dawley , Medição de Risco , Sotalol/toxicidadeRESUMO
Microplastics and pharmaceuticals are considered ubiquitous and emergent pollutants of high concern but the knowledge on their effects on primary producers is still limited, especially those caused by mixtures. Thus, the goal of the present study was to investigate if the presence of microplastics (1-5⯵m diameter) influences the toxicity of the pharmaceuticals procainamide and doxycycline to the marine microalga Tetraselmis chuii. Bioassays (96â¯h) to investigate the toxicity of those substances individually and in mixtures (i.e. microplastics-procainamide mixtures and microplastics-doxycycline mixtures) were carried out. Effect criteria were the average specific growth rate (growth rate) and chlorophyll a concentration (chlorophyll). EC10, EC20 and EC50 were determined. Microplastics alone had no significant effects on growth rate up to 41.5â¯mg/l, whereas chlorophyll was significantly reduced at 0.9 and 2.1â¯mg/l of microplastics, but not at higher concentrations. The 96â¯h EC50 (growth rate and chlorophyll, respectively) determined for the other bioassays were: 104 and 143â¯mg/l for procainamide alone; 125 and 31â¯mg/l for procainamide in the presence of microplastics; 22 and 14â¯mg/l for doxycycline alone; 11 and 7â¯mg/l for doxycycline in the presence of microplastics. Significant differences (pâ¯<â¯0.001) between the toxicity curves of each pharmaceutical alone and in mixture with microplastics were found for procainamide (chlorophyll), and doxycycline (both parameters). Thus, both pharmaceuticals were toxic to T. chuii in the low ppm range, and microplastics-pharmaceutical mixtures were more toxic than the pharmaceuticals alone. Very high decreases of doxycycline concentrations in test media were found, indicating degradation of the antibiotic. Thus, although the biological results are expressed in relation to doxycycline concentration, the effects were likely caused by a mixture of the parental compound and its degradation products. The concentrations of microplastics and pharmaceuticals tested (low ppm range) are higher than those expected to be found in waters of the most part of marine ecosystems (ppt or ppb ranges). However, considering the widespread contamination by microplastics and pharmaceuticals, the concentrations already found in waters, sediments and/or organism of heavily polluted areas, the long-term exposure (over generations) of wild populations to such substances in polluted ecosystems and the possibilities of bioaccumulation and toxicological interactions, these findings are of concern and further research on microplastics-pharmaceuticals toxicological interactions is needed.
Assuntos
Organismos Aquáticos/metabolismo , Clorófitas/metabolismo , Doxiciclina/toxicidade , Microalgas/metabolismo , Plásticos/toxicidade , Procainamida/toxicidade , Antibacterianos/toxicidade , Organismos Aquáticos/efeitos dos fármacos , Clorófitas/efeitos dos fármacos , Microalgas/efeitos dos fármacos , Microalgas/crescimento & desenvolvimento , Preparações Farmacêuticas , Poluentes Químicos da Água/toxicidadeRESUMO
Drug-induced autoimmunity (DIA) refers to a group of adverse drug reactions, and they remain unpredictable largely due to the limited understanding of the mechanisms involved. There is evidence that procainamide can cause autoimmune reactions in humans but the mechanisms involved remain unclear. To examine the cellular and genetic factors involved in the procainamide-induced autoimmune response, we compared rats that are genetically T-helper (Th)2-predisposed (Brown Norway (BN)), Th1-predisposed (Lewis (LEW)) or not genetically predisposed (Sprague Dawley (SD)). We revealed significant differences in response to autoimmunity induced by procainamide among three strains rats, BN was the most sensitive one, SD exhibited less sensitive, while LEW resistance to procainamide. Much more pronounced of Th2-type responses and more complex differentially expressed genes involved in immune regulation and response in BN might contribute to its susceptibleness to DIA. Moreover, similar immune mechanisms were found between BN and SD, which suggesting that these changes would serve as the potential bridge biomarkers to predict DIA among species. This study may also benefit to further understand the toxicological mechanism of drug-induced autoimmune reactions.
Assuntos
Autoimunidade/efeitos dos fármacos , Procainamida/toxicidade , Linfócitos T/efeitos dos fármacos , Animais , Antiarrítmicos/toxicidade , Anticorpos Antinucleares/sangue , Autoimunidade/imunologia , Linfócitos B/efeitos dos fármacos , Linfócitos B/imunologia , Citocinas/sangue , Masculino , Ratos Endogâmicos BN , Ratos Endogâmicos Lew , Ratos Sprague-Dawley , Baço/efeitos dos fármacos , Baço/patologia , Linfócitos T/imunologiaRESUMO
Procainamide is class Ia Na(+) channel blocker that may prolong ventricular repolarization secondary to inhibition of IK r , the rapid component of the delayed rectifier K(+) current. In contrast to selective IN a blockers such as lidocaine, procainamide was shown to produce arrhythmogenic effects in the clinical setting. This study examined whether pro-arrhythmic responses to procainamide may be accounted for by drug-induced repolarization abnormalities including impaired electrical restitution kinetics, spatial gradients in action potential duration (APD), and activation-to-repolarization coupling. In perfused guinea-pig hearts, procainamide was found to prolong the QT interval on ECG and left ventricular (LV) epicardial monophasic APD, increased the maximum slope of electrical restitution, enhanced transepicardial APD variability, and eliminated the inverse correlation between the local APD and activation time values determined at distinct epicardial recording sites prior to drug infusion. In contrast, lidocaine had no effect on electrical restitution, the degree of transepicardial repolarization heterogeneities, and activation-to-repolarization coupling. Spontaneous episodes of monomorphic ventricular tachycardia were observed in 57% of procainamide-treated heart preparations. No arrhythmia was induced by lidocaine. In summary, this study suggests that abnormal changes in repolarization may contribute to pro-arrhythmic effects of procainamide.
Assuntos
Antiarrítmicos/toxicidade , Arritmias Cardíacas/induzido quimicamente , Lidocaína/toxicidade , Procainamida/toxicidade , Potenciais de Ação/efeitos dos fármacos , Animais , Antiarrítmicos/farmacologia , Arritmias Cardíacas/fisiopatologia , Eletrocardiografia , Feminino , Cobaias , Lidocaína/farmacologia , Síndrome do QT Longo/induzido quimicamente , Síndrome do QT Longo/fisiopatologia , Procainamida/farmacologia , Taquicardia Ventricular/induzido quimicamente , Taquicardia Ventricular/fisiopatologia , Bloqueadores do Canal de Sódio Disparado por Voltagem/farmacologia , Bloqueadores do Canal de Sódio Disparado por Voltagem/toxicidadeRESUMO
Non-bilayer phospholipid arrangements are three-dimensional structures that can form when anionic phospholipids with an intermediate form of the tubular hexagonal phase II (H(II)), such as phosphatidic acid, phosphatidylserine or cardiolipin, are present in a bilayer of lipids. The drugs chlorpromazine and procainamide, which trigger a lupus-like disease in humans, can induce the formation of non-bilayer phospholipid arrangements, and we have previously shown that liposomes with non-bilayer arrangements induced by these drugs cause an autoimmune disease resembling human lupus in mice. Here we show that liposomes with non-bilayer phospholipid arrangements induced by Mn²âº cause a similar disease in mice. We extensively characterize the physical properties and immunological reactivity of liposomes made of the zwitterionic lipid phosphatidylcholine and a H(II)-preferring lipid, in the absence or presence of Mn²âº, chlorpromazine or procainamide. We use an hapten inhibition assay to define the epitope recognized by sera of mice with the disease, and by a monoclonal antibody that binds specifically to non-bilayer phospholipid arrangements, and we report that phosphorylcholine and glycerolphosphorylcholine, which form part of the polar region of phosphatidylcholine, are the only haptens that block the binding of the tested antibodies to non-bilayer arrangements. We propose a model in which the negatively charged H(II)-preferring lipids form an inverted micelle by electrostatic interactions with the positive charge of Mn²âº, chlorpromazine or procainamide; the inverted micelle is inserted into the bilayer of phosphatidylcholine, whose polar regions are exposed and become targets for antibody production. This model may be relevant in the pathogenesis of human lupus.
Assuntos
Lúpus Eritematoso Sistêmico/metabolismo , Lipossomas Unilamelares/metabolismo , Animais , Anticorpos/sangue , Anticorpos/metabolismo , Anticorpos Monoclonais/metabolismo , Cardiolipinas/química , Cardiolipinas/imunologia , Bovinos , Clorpromazina/toxicidade , Glomérulos Renais/patologia , Lúpus Eritematoso Sistêmico/induzido quimicamente , Lúpus Eritematoso Sistêmico/imunologia , Lúpus Eritematoso Sistêmico/patologia , Manganês/toxicidade , Camundongos , Modelos Moleculares , Ressonância Magnética Nuclear Biomolecular , Ácidos Fosfatídicos/química , Ácidos Fosfatídicos/imunologia , Fosfatidilcolinas/química , Fosfatidilcolinas/imunologia , Fosfatidilserinas/química , Fosfatidilserinas/imunologia , Procainamida/toxicidade , Pele/patologia , Lipossomas Unilamelares/química , Lipossomas Unilamelares/imunologiaRESUMO
DNA methylation plays an essential role in maintaining T-cell function. A growing body of literature indicates that failure to maintain DNA methylation levels and patterns in mature T cells can result in T-cell autoreactivity in vitro and autoimmunity in vivo. Defective maintenance of DNA methylation may be caused by drugs such as procainamide or hydralazine, or failure to activate the genes encoding maintenance DNA methyltransferases during mitosis, resulting in the development of a lupus-like disease or perhaps other autoimmune disorders. This paper reviews the evidence supporting a role for abnormal T-cell DNA methylation in causing autoimmunity in an animal model of drug-induced lupus, and discusses some of the mechanisms involved. T cells from patients with active lupus have evidence for most if not all of the same methylation abnormalities, suggesting that abnormal DNA methylation plays a role in idiopathic human lupus as well.
Assuntos
Doenças Autoimunes/metabolismo , Metilação de DNA , Animais , Doenças Autoimunes/etiologia , Doenças Autoimunes/imunologia , Autoimunidade/efeitos dos fármacos , Azacitidina/toxicidade , Comunicação Celular/efeitos dos fármacos , Comunicação Celular/imunologia , Metilação de DNA/efeitos dos fármacos , Humanos , Hidralazina/toxicidade , Técnicas In Vitro , Lúpus Eritematoso Sistêmico/etiologia , Modelos Imunológicos , Procainamida/toxicidade , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia , Linfócitos T/metabolismoRESUMO
Declopramide (3-chloroprocainamide) has been identified in previous studies as a representative of a new class of chemosensitizers. In this study, the toxicity and pharmacokinetics of declopramide have been investigated and compared with a structural analog, metoclopramide (MCA). Declopramide has not induced central nervous system (CNS)-related side effects in rats at doses up to 200 mg/kg, whereas MCA does at 12.5 mg/kg. In addition, declopramide did not bind to dopamine D2 receptors in subcellular preparations at doses up to 100 microM, whereas MCA showed affinity at 1 microM. Declopramide bound with affinity to 5-hydroxytryptamine3 receptors which are important in controlling vomiting. In contrast to MCA, declopramide has a rapid clearance from serum, a lower tissue concentration (about 15-fold lower than MCA) and a lower oral bioavailability (about 6-fold lower than MCA). However, declopramide was shown in vitro to possess a higher tumor cell absorption rate. One of the main metabolites of declopramide was identified as N-acetyl declopramide. Taken together, these data suggest that the clinical development of declopramide as a sensitizer of radio- and chemotherapies is an improvement over MCA, because it can be administered in a high dose and is devoid of CNS side effects.
Assuntos
Sistema Nervoso Central/efeitos dos fármacos , Procainamida/análogos & derivados , Administração Oral , Animais , Antieméticos/farmacocinética , Antieméticos/toxicidade , Disponibilidade Biológica , Antagonistas de Dopamina/farmacocinética , Antagonistas de Dopamina/toxicidade , Relação Dose-Resposta a Droga , Feminino , Metoclopramida/farmacocinética , Metoclopramida/toxicidade , Camundongos , Camundongos SCID , Procainamida/metabolismo , Procainamida/farmacocinética , Procainamida/toxicidade , Ratos , Ratos Wistar , Receptores de Dopamina D2/metabolismo , Receptores de Serotonina/metabolismo , Receptores 5-HT3 de Serotonina , Fases do Sono/efeitos dos fármacos , Distribuição TecidualAssuntos
Antiarrítmicos/toxicidade , Benzamidas/farmacologia , Cardiotônicos/farmacologia , Morfolinas/farmacologia , Succinatos/farmacologia , Triptofano/análogos & derivados , Amiodarona/toxicidade , Animais , Antiarrítmicos/farmacologia , Benzimidazóis/toxicidade , Dibenzazepinas/toxicidade , Antagonismo de Drogas , Eletrocardiografia , Lidocaína/toxicidade , Masculino , Procainamida/toxicidade , Propranolol/toxicidade , Ratos , Ratos Wistar , Triptofano/farmacologia , Verapamil/toxicidadeRESUMO
A side effect of therapy with procainamide and numerous other medications is a lupus-like syndrome characterized by autoantibodies directed against denatured DNA and the (H2A-H2B)-DNA subunit of chromatin. We tested the possibility that an effect of lupus-inducing drugs on central T cell tolerance underlies these phenomena. Two intrathymic injections of procainamide-hydroxylamine (PAHA), a reactive metabolite of procainamide, resulted in prompt production of IgM antidenatured DNA antibodies in C57BL/6xDBA/2 F1 mice. Subsequently, IgG antichromatin antibodies began to appear in the serum 3 wk after the second injection and were sustained for several months. Specificity, inhibition and blocking studies demonstrated that the PAHA-induced antibodies showed remarkable specificity to the (H2A-H2B)-DNA complex. No evidence for polyclonal B cell activation could be detected based on enumeration of Ig-secreting B cells and serum Ig levels, suggesting that a clonally restricted autoimmune response was induced by intrathymic PAHA. The IgG isotype of the antichromatin antibodies indicated involvement of T cell help, and proliferative responses of splenocytes to oligonucleosomes increased up to 100-fold. As little as 5 microM PAHA led to a 10-fold T cell proliferative response to chromatin in short term organ culture of neonatal thymi. We suggest that PAHA interferes with self-tolerance mechanisms accompanying T cell maturation in the thymus, resulting in the emergence of chromatin-reactive T cells followed by humoral autoimmunity.
Assuntos
Autoimunidade , Tolerância Imunológica/efeitos dos fármacos , Lúpus Eritematoso Sistêmico/induzido quimicamente , Lúpus Eritematoso Sistêmico/imunologia , Procainamida/análogos & derivados , Linfócitos T/efeitos dos fármacos , Linfócitos T/metabolismo , Transferência Adotiva , Animais , Anticorpos Antinucleares/biossíntese , Modelos Animais de Doenças , Feminino , Humanos , Imunidade Celular/efeitos dos fármacos , Técnicas In Vitro , Ativação Linfocitária , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Camundongos Endogâmicos MRL lpr , Camundongos Endogâmicos NZB , Procainamida/toxicidade , Timo/efeitos dos fármacos , Timo/imunologiaRESUMO
3-Chloroprocainamide (3-CPA), an analog of metoclopramide (MCA), dose-dependently inhibited tumor growth in scid mice xenografted with a human brain astrocytoma (T24) when given intramuscularly to mice every third day for 14-20 days. 3-CPA was shown to have the same efficacy on tumor growth inhibition as neutral metoclopramide (neutral MCA) at the doses of 10-40 mg/kg when evaluated by tumor doubling time, tumor growth time for tumor volumes to reach 1000 mm3 and area under growth curve. 3-CPA at the dose of 3 x 40 mg/kg was also shown to enhance the cytotoxicity induced by a single dose of cisplatin at 7.5 mg/kg. A dose of < or = 160 mg/kg of 3-CPA did not show any notable extrapyramidal symptoms which was observed for neutral MCA treated mice at the dose of 20 mg/kg. The lethal response dose of 3-CPA for scid mice was 320 mg/kg which is 4 times higher than that determined for neutral MCA (80 mg/kg). These results support 3-CPA as a good candidate drug representing a new generation of benzamides for further clinical development as a cancer therapy drug.
Assuntos
Astrocitoma/tratamento farmacológico , Neoplasias Encefálicas/tratamento farmacológico , Procainamida/análogos & derivados , Animais , Antineoplásicos/farmacologia , Cisplatino/farmacologia , Relação Dose-Resposta a Droga , Interações Medicamentosas , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Humanos , Masculino , Metoclopramida/farmacologia , Metoclopramida/toxicidade , Camundongos , Camundongos SCID , Transplante de Neoplasias , Procainamida/farmacologia , Procainamida/toxicidade , Transplante HeterólogoRESUMO
The role of human granulocytes in the promotion of procainamide (PA) toxicity in vitro has been studied and one of the agents responsible for DNA strand scission and cell death in human target cells has been characterized. Crude peripheral blood mononuclear cells (cPBMNs) isolated by density centrifugation, and the lymphocyte cell lines--CCRF-HSB2 and WIL-2NS--were exposed to PA, and DNA strand breaks were quantified by fluorescent analysis of DNA unwinding. Therapeutic plasma concentrations of PA (0-50 microM) caused dose-dependent cytotoxicity, determined by dye exclusion, and strand breaks in cPBMNs incubated for 3 and 1.5 hr at 37 degrees, respectively. Using 50 microM PA a five-fold increase in DNA strand breaks was observed after 1.5 hr, with significant induction of strand breaks also being observed for 10 and 25 microM concentrations. Toxicity was much reduced in lymphocyte cell lines (maximal killing = 3.0% at 50 microM PA compared with 13.2% in cPBMNs). A similar decrease in toxicity was observed where N-acetyl procainamide (NAPA) was substituted for PA (less than 50% of strand breaks at all concentrations). Further investigations showed that the presence of a contaminating granulocyte population in the cPBMN fraction was responsible for the induction of PA toxicity. Incubation of a highly enriched granulocyte population with PA for 1 hr prior to exposure to purified peripheral blood mononuclear cells (pPBMNs) led to the complete restoration of the toxic effects. The resulting cyto- and genotoxicity were not significantly different to levels observed in cPBMNs. Significantly, incubation of granulocytes with NAPA did not induce toxicity in target pPBMNs. Ultrafiltration of granulocyte supernatants led to the identification of two toxic fractions of < 3000 and > 30,000 Da. Temporal studies showed that the toxicity associated with the < 3000 Da fraction appeared during the first 10-15 min incubation with PA whereas the > 30,000 Da fraction did not display significant toxicity until the 40-60 min period. Further assessment of the nature of these agents indicated that the 30,000 Da fraction was a protein. SDS-PAGE analysis showed an inducible 17,800 Da species appearing in granulocyte supernatants after 40 min incubation with PA. Dot blot analysis indicated that tumour necrosis factor alpha (TNF alpha) was present in the > 30,000 Da fraction. Evidence that TNF alpha was the high-molecular weight species responsible for PA-induced toxicity was obtained from neutralization assays employing an anti-TNF alpha antibody.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Granulócitos/efeitos dos fármacos , Procainamida/toxicidade , Fator de Necrose Tumoral alfa/metabolismo , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Granulócitos/metabolismo , HumanosRESUMO
Metoclopramide (MCA) and procainamide (PCA), two widely used benzamide drugs developed before the present regulatory climate but recently found to induce DNA breaks in human lymphocytes, were evaluated for their genotoxic effects in cultured rodent and human cells. In subtoxic concentrations neither MCA (from 0.10 to 0.32 mM) nor PCA (from 0.18 to 0.56 mM) induced DNA fragmentation and repair in primary cultures of metabolically competent rat and human hepatocytes. In the absence of metabolic activation a meaningful increase in the frequency of 6-thioguanine-resistant V79 cells was produced by the maximum tolerated concentration of MCA (3.2 mM), whereas PCA resulted nonmutagenic. Any clastogenic effect was absent in human lymphocytes exposed to MCA for 28 hr, but a statistically significant increase in the frequency of micronucleated cells was observed when the exposure was prolonged to 72 hr. In contrast, PCA was never clastogenic under the same experimental conditions. These results suggest that of the two benzamides tested only MCA should be considered potentially capable of producing mutagenic and clastogenic effects; it presumably behaves as an agent which is rapidly transformed by the liver into inactive metabolites, and the clinical relevance of its genotoxic activity remains to be ascertained.
Assuntos
Metoclopramida/toxicidade , Mutagênicos/toxicidade , Procainamida/toxicidade , Animais , Autorradiografia , Células Cultivadas , Cricetinae , Cricetulus , Reparo do DNA , DNA de Cadeia Simples/efeitos dos fármacos , Humanos , Fígado/efeitos dos fármacos , Pulmão/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Masculino , Micronúcleos com Defeito Cromossômico/efeitos dos fármacos , Testes de Mutagenicidade , Ratos , Ratos Sprague-DawleyRESUMO
The DNA-damaging and clastogenic activities of metoclopramide (MCA) and procainamide (PCA), two substituted benzamides not systematically tested for genotoxicity before clinical use, were investigated in rats given a single high oral dose (500 mg/kg) of these drugs. Neither MCA nor PCA induced DNA fragmentation in liver, kidney, gastric mucosa, spleen, and bone marrow, as detected by the alkaline elution technique. Moreover, neither drug increased the frequency of micronucleated hepatocytes and the frequency of micronucleated polychromatic erythrocytes in the bone marrow of partially hepatectomized rats. However, in rats initiated with N-nitrosodiethylamine and given water containing 0.125% MCA for 14 successive days a clear-cut and statistically significant increase in the number and size of liver gamma-glutamyltranspeptidase-positive foci and basophilic foci, which are consistent with potential promoting activity, was observed. Under the same experimental conditions the effect of PCA was markedly lower, only limited to a modest increase of the number and area of gamma-glutamyltranspeptidase-positive foci.
Assuntos
DNA/efeitos dos fármacos , Metoclopramida/toxicidade , Mutagênicos/toxicidade , Procainamida/toxicidade , Administração Oral , Animais , Carcinógenos/toxicidade , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Testes para Micronúcleos , Compostos Nitrosos/toxicidade , Ratos , Ratos Sprague-DawleyAssuntos
Doenças Autoimunes/induzido quimicamente , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Autoimunidade , Tiomalato Sódico de Ouro/metabolismo , Tiomalato Sódico de Ouro/toxicidade , Camundongos , Neutrófilos/fisiologia , Procainamida/metabolismo , Procainamida/toxicidade , Propiltiouracila/metabolismo , Propiltiouracila/toxicidadeRESUMO
Drug-induced lupus is a serious side effect of certain medications, but the chemical features that confer this property and the underlying pathogenesis are puzzling. Prototypes of all six therapeutic classes of lupus-inducing drugs were highly cytotoxic only in the presence of activated neutrophils. Removal of extracellular hydrogen peroxide before, but not after, exposure of the drug to activated neutrophils prevented cytotoxicity. Neutrophil-dependent cytotoxicity required the enzymatic action of myeloperoxidase, resulting in the chemical transformation of the drug to a reactive product. The capacity of drugs to serve as myeloperoxidase substrates in vitro was associated with the ability to induce lupus in vivo.
Assuntos
Morte Celular/efeitos dos fármacos , Lúpus Eritematoso Sistêmico/induzido quimicamente , Ativação de Neutrófilo , Neutrófilos/metabolismo , Peroxidase/metabolismo , Animais , Bioensaio , Biotransformação , Clorpromazina/análogos & derivados , Clorpromazina/metabolismo , Clorpromazina/toxicidade , Humanos , Hidralazina/análogos & derivados , Hidralazina/metabolismo , Hidralazina/toxicidade , Peróxido de Hidrogênio/metabolismo , Isoniazida/análogos & derivados , Isoniazida/metabolismo , Isoniazida/toxicidade , Camundongos , Neutrófilos/enzimologia , Procainamida/análogos & derivados , Procainamida/metabolismo , Procainamida/toxicidade , Propiltiouracila/análogos & derivados , Propiltiouracila/metabolismo , Propiltiouracila/toxicidade , Quinidina/análogos & derivados , Quinidina/metabolismo , Quinidina/toxicidade , Células Tumorais CultivadasRESUMO
Outbred (namely Wistar and Sprague-Dawley) and inbred (Wistar-Furth, Lewis, Fisher 344 and Brown-Norway) strains of rats were screened for their responses to reference compounds in the popliteal lymph node (PLN) assay. Streptozotocin and diphenylhydantoin gave positive responses as evidenced by increased weight and cellularity indices in all strains used whereas procainamide, isoniazid and barbital consistently gave negative responses. Although these findings overall are in agreement with previous investigations involving these compounds, the lack of marked interstrain differences in PLN responses argues against a strong immunogenetically controlled mechanism as could be assumed in presumably auto-immune reactions. The question is raised whether drug-induced side-effects predicted by the PLN assay are basically non-autoimmune as suggested by clinical and immunological findings in man.
Assuntos
Linfonodos/efeitos dos fármacos , Animais , Barbital/toxicidade , Feminino , Membro Posterior , Isoniazida/toxicidade , Masculino , Fenitoína/toxicidade , Procainamida/toxicidade , Ratos , Ratos Endogâmicos , Ratos Sprague-Dawley , Ratos Wistar , Especificidade da Espécie , Estreptozocina/toxicidadeRESUMO
The drug procainamide (PA) is notorious for causing drug-induced systemic lupus erythematosus (SLE) in humans. Indirect evidence suggests that metabolism of PA to a reactive intermediate metabolite is involved in the pathogenesis of drug-induced SLE in that N-hydroxylation of the arylamine group of PA favors this condition, whereas N-acetylation prevents it. If this is correct, one would expect hydroxylamine-PA (HAPA) to be immunogenic, whereas N-acetyl-PA (N-ac-PA) should be nonimmunogenic. This hypothesis was confirmed by means of the popliteal lymph node assay (PLNA) in mice: injection of PA and N-ac-PA failed to induce a reaction in the direct PLNA, whereas HAPA induced a vigorous reaction. Using the adoptive transfer PLNA, splenic T cells of mice that had received three injections of HAPA were shown to be specifically sensitized to this metabolite, but not to PA or N-ac-PA. In this system, an anamnestic T cell response could also be elicited when homogenized peritoneal cells of mice that had been treated with PA for 4 months were used as the challenging antigen, indicating that the peritoneal cells of PA-treated animals contained or had been exposed to the reactive intermediate metabolite HAPA. Whereas in slow acetylator mice this 4-month PA treatment sufficed to generate HAPA in peritoneal cells, fast acetylators required additional stimulation of their oxidative metabolism in order to produce enough HAPA detectable by sensitized T cells. These findings clearly support the concept that reactive intermediate metabolites, such as HAPA, are generated by the oxidative metabolism of phagocytic cells and are immunogenic for T cells.
Assuntos
Acecainida/toxicidade , Linfonodos/efeitos dos fármacos , Procainamida/análogos & derivados , Procainamida/toxicidade , Linfócitos T/imunologia , Acecainida/imunologia , Acetilação , Animais , Feminino , Humanos , Hidroxilação , Memória Imunológica , Linfonodos/imunologia , Camundongos , Camundongos Endogâmicos A , Camundongos Endogâmicos C57BL , Cavidade Peritoneal/citologia , Fagócitos/metabolismo , Procainamida/imunologia , Procainamida/metabolismo , Baço/citologia , Linfócitos T/efeitos dos fármacosRESUMO
1. N-hydroxylation is thought to be an essential step in the haemotoxicity of dapsone (DDS). To investigate both metabolism-dependent and cell-selective drug toxicity in vitro we have developed a three-compartment system in which an hepatic drug metabolizing system is contained within a central compartment separated by semipermeable membranes from compartments containing mononuclear leucocytes (MNL) and red blood cells (RBC). 2. Metabolism of dapsone (100 microM) by rat liver microsomes resulted in toxicity to RBC cells (47.3 +/- 2.1% methaemoglobin), but there was no significant toxicity toward MNL (3.7 +/- 1.3% cell death) compared with control values (1.6 +/- 0.9%). However, when RBC were replaced with buffer in the third compartment there was significantly greater (P < 0.001) white cell toxicity (17.6 +/- 0.6% cell death), demonstrating the protection of MNL by RBC. Metabolism of dapsone by human liver microsomes again resulted in RBC toxicity (12.5 +/- 3.3% methaemoglobin) but no significant MNL toxicity (2.9 +/- 0.8% cell death). Replacement of RBC resulted in a significant (P < 0.001) increase in MNL toxicity (6.5 +/- 0.7% cell death). Addition of synthetic dapsone hydroxylamine (30 microM) in the absence of a metabolizing system and with no RBC in the third compartment resulted in significant (P < 0.001) toxicity toward MNL (43.36 +/- 5.82% cell death) compared with control (1.8 +/- 1.1%). The presence of RBC in the third compartment resulted in a significant (P < 0.001) decrease in MNL toxicity (17.6 +/- 2.2% cell death), with 40.1 +/- 3.7% methaemoglobin in the RBC.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Doenças Hematológicas/induzido quimicamente , Fígado/metabolismo , Preparações Farmacêuticas/metabolismo , Animais , Dapsona/metabolismo , Dapsona/toxicidade , Contagem de Eritrócitos/efeitos dos fármacos , Humanos , Hidralazina/metabolismo , Hidralazina/toxicidade , Técnicas In Vitro , Masculino , Metemoglobina/metabolismo , Microssomos Hepáticos/metabolismo , Modelos Biológicos , Neutrófilos/efeitos dos fármacos , Primaquina/metabolismo , Primaquina/toxicidade , Procainamida/metabolismo , Procainamida/toxicidade , Ratos , Ratos WistarRESUMO
Free radical processes are proposed to play a crucial role in the development of procainamide adverse effects. Therefore, selenium, as a potent antioxidant, may modified procainamide toxicity. To test this hypothesis plasma and liver thiobarbituric acid-reacting substances (TBARS), plasma antioxidant activity (AOA), erythrocyte and liver superoxide dismutase (SOD), catalase, as well as selenium-dependent glutathione peroxidase (Se-GPX) were determined in the following four groups of rats: selenium-treated (Se), procainamide-treated (P), procainamide and selenium-treated (P + Se), and control (C). Morphological studies of leukocytes [tested for lupus erythematosus (LE) cells] and liver were also made. Atypical, i.e. enlarged and swollen, leukocytes resulting from procainamide and selenium treatment were observed. These changes were found in four out of five rats in the Se group, eight out of ten in the P group, and in seven out of ten in the P + Se group. LE-like cells were observed in two rats in the P + Se group. A statistically significant decrease in plasma and liver TBARS by 20% and 36%, respectively, increased activity of SOD by 20%, catalase by 48% and Se-GPX by 15% in erythrocytes, and decreased activity of liver SOD by 17% and catalase by 22% were found in the P + Se group as compared to the P group. These results indicated that selenium exerted antioxidant effects on the procainamide-treated rats. However, selenium did not prevent the development of disturbances in leukocyte morphology, on the contrary, it possibly promoted the conversion of leukocytes to LE cells.
Assuntos
Procainamida/toxicidade , Selênio/farmacologia , Animais , Antioxidantes/análise , Feminino , Radicais Livres , Peroxidação de Lipídeos , Ratos , Ratos Wistar , LevedurasRESUMO
The popliteal lymph node assay (PLNA) was proposed for the preclinical prediction of xenobiotics-induced autoimmune reactions in humans. Among the substances so far tested in this model, procainamide and isoniazid gave negative PLNA responses despite reports of lupus syndromes in man. To confirm the hypothesis that a metabolite instead of the parent molecule is involved, rats were pretreated with phenobarbital or beta-naphthoflavone, then injected with procainamide or isoniazid. In additional groups of animals, procainamide or isoniazid were injected together with S9-mix following various incubation times. Pretreated rats had a positive PLNA response when injected with procainamide, whereas preincubation with S9-mix resulted in a positive response to isoniazid. These results further support the validity of the PLNA.